Newsbenzinga
Turn Therapeutics Completes Comprehensive Interim Analysis Of Ongoing Adaptive Phase 2 Clinical Trial Evaluating GX-03 For Treatment Of Atopic Dermatitis
· Published
Article summary
Please check the source for details.
An excerpt from the original article.
Comments —
Loading comments…